Access to medicines in least developed countries a success without CAMR
Bill C-393 seeks to amend Canada's Access to Medicines Regime passed in 2004 that allows generic drug manufacturers to be granted a 'compulsory licence' to manufacture and export a generic version of a brand-name drug to a developing country facing an eme
Although it is commendable that Canadian Parliamentarians wish to do their part in saving lives around the world, private member's Bill C-393 which is being debated in the House of Commons, is not the route to follow.
SPONSORED CONTENT
Get Today’s Headlines Newsletter
Your quick scan of the news you need each weekday to be the smartest person in the room.
By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy
